Page 3,690«..1020..3,6893,6903,6913,692..3,7003,710..»

Makeshift chemistry (vocal cover) – Video

Posted: Published on September 2nd, 2014

Makeshift chemistry (vocal cover) By: Mr.brightside69 … Continue reading

Posted in Chemistry | Comments Off on Makeshift chemistry (vocal cover) – Video

How to get the rainbow beaker in bradys chemistry set – Video

Posted: Published on September 2nd, 2014

How to get the rainbow beaker in bradys chemistry set Hope this helps! By: garrett animaljam … Continue reading

Posted in Chemistry | Comments Off on How to get the rainbow beaker in bradys chemistry set – Video

AP Chemistry measuring with two balances everett and masoud – Video

Posted: Published on September 2nd, 2014

AP Chemistry measuring with two balances everett and masoud By: Everett Johnson … Continue reading

Posted in Chemistry | Comments Off on AP Chemistry measuring with two balances everett and masoud – Video

Bromine Chemistry School Project – Video

Posted: Published on September 2nd, 2014

Bromine Chemistry School Project A school science project done by me, and my classmates Yan Hwee, Fiona and Jared. By: Edith Studios … Continue reading

Posted in Chemistry | Comments Off on Bromine Chemistry School Project – Video

Chemist and Manhattan Project alum Robert Connick has died at 97

Posted: Published on September 2nd, 2014

Robert E. Connick (1917-2014) Aug 28, 2014 Professor Robert E. Connick. Professor Robert E. Connick, esteemed professor emeritus of chemistry and alumnus of the College, has died at the age of 97. He passed away peacefully at his home in Kensington, CA, on Thursday, August 21. Bob Connick was born in Eureka, CA, on July 29, 1917. He moved with his family to the city of Berkeley when he was 12 years old. After attending Berkeley High, he enrolled at UC Berkeley and earned both a B.S. (39) and a Ph.D. (42) in the College of Chemistry, with William Bray as his research director. Hired at Berkeley as an instructor in 1943, he immediately joined the Manhattan Project, studying the chemistry of plutonium and devising separation techniques. Through the decades, his areas of research included NMR, reaction kinetics, ligand exchange reactions, hydrolytic oligomerization, ruthenium chemistry, sulfur chemistry and computer modeling of exchange reactions. Bob Connick became a full professor in 1952, the same year that he married Frances Spieth, a Ph.D. alumna of the College of Chemistry, who had earned her doctorate in chemistry in 1947 working with Axel Olson. Frances, who died in 2009 at the age of 86, … Continue reading

Posted in Chemistry | Comments Off on Chemist and Manhattan Project alum Robert Connick has died at 97

1 Reason Nancy Nayor Says Chemistry was Key for The Remaining

Posted: Published on September 2nd, 2014

By Melinda Loewenstein | Posted Sept. 1, 2014, 11:17 p.m. Photo Source: Courtesy of Affirm Films Former Universal Studios casting executive Nancy Nayor has always been a fan of the horror and sci-fi genres, but after casting The Grudge and The Exorcism of Emily Rose, she began receiving offers for more genre projects, like Casey La Scalas latest film, The Remaining. The Christian movie revolves around a group of friends celebrating the wedding of Dan (Bryan Dechart) and Skylar (Alexa Vega) when the Rapture hits and they are caught up in a dramatic end-of-the-world scenario. Having cast actors Adam Brody, Jennifer Morrison, and Mike Vogel early in their careers in La Scalas first film, Grind, Nayor says she knew he was going to have great taste in actors. Nayor and casting colleague Andy Henry had extensive mix-and-match chemistry read sessions, because La Scala wanted the actors to have real chemistry. And with no actors attached, Nayor started from scratch: Its fulfilling to build an ensemble from the ground up. Nayor and Henry are especially proud of the ensembles chemistry: [It] felt really great that they did feel like friends. I pride myself on casting actors that play well with others … Continue reading

Posted in Chemistry | Comments Off on 1 Reason Nancy Nayor Says Chemistry was Key for The Remaining

ESC TV 2014 – e-Health: A vital part of modern cardiology – Video

Posted: Published on September 2nd, 2014

ESC TV 2014 - e-Health: A vital part of modern cardiology Interviewee : Prof. Martin Cowie, FESC, London, United Kingdom Interviewer : Dr. Enno van der Velde, FESC, Leiden, Netherlands ESC Congress 2014 : Smartphone... By: European Society of Cardiology … Continue reading

Posted in Cardiology | Comments Off on ESC TV 2014 – e-Health: A vital part of modern cardiology – Video

ROCKET AF trial suggests that digoxin increases risk of death in AF patients

Posted: Published on September 2nd, 2014

PUBLIC RELEASE DATE: 2-Sep-2014 Contact: ESC Press Office press@escardio.org 34-670-521-210 European Society of Cardiology Barcelona, Spain Tuesday 2 September 2014: Digoxin may increase the risk of death in patients with atrial fibrillation (AF) by approximately 20%, according to results from the ROCKET AF trial presented at ESC Congress today by Dr Manesh Patel, director of interventional cardiology and catheterisation labs at Duke University Health System in Durham, North Carolina, US. The findings suggest that caution may be needed when using digoxin in complex AF patients but further studies are needed to confirm the observations. Dr Patel said: "In this subanalysis of the ROCKET AF trial we found that AF patients who took the drug digoxin had an increased risk of adverse cardiovascular events, including vascular death or sudden death." He added: "Digoxin, which works to strengthen heart contractions, is one of the oldest medications used in the treatment of patients with heart failure and it has also been used in patients who have AF. However the use of digoxin in AF patients has not been rigorously studied in randomised trials. We therefore conducted a retrospective subanalysis of the ROCKET AF trial to determine the effect of digoxin on the risk … Continue reading

Posted in Cardiology | Comments Off on ROCKET AF trial suggests that digoxin increases risk of death in AF patients

Studies Support Growing Use Of New Technology To Improve Stenting

Posted: Published on September 2nd, 2014

In recent years interventional cardiologists have started to use a new catheter technique, called fractional flow reserve (FFR), in an attempt to assess which blocked vessels might benefit from a stent.Two studies presented at the European Society of Cardiology meeting in Barcelona offered new support for FFR, which has been slowly but surely gaining traction in the interventional cardiology community. Bernard De Bruyne presented 2-year results from the FAME 2 (Fractional flow reserve versus Angiography for Multivessel Evaluation 2) study (simultaneously published in theNew England Journal of Medicine). FAME 2 was designed to find out whether PCI, with the help of FFR, can reduce the rate of hard endpoints in stable coronary artery disease compared to medical therapy. (FAME 2 was sponsored by St. Jude Medical, which makes an FFR pressure wire. Another major player in the field is the Volcano Corporation.) 1220 patients with stable CAD underwent angiography with FFR. 27% of the group had no ischemic lesions on FFR (>.80 pressure gradient) and were entered in a separate registry. 73% had at least one stenosis with a pressure gradient of .80 or under and were randomized to PCI and medical therapy or medical therapy alone. At 2 years … Continue reading

Posted in Cardiology | Comments Off on Studies Support Growing Use Of New Technology To Improve Stenting

Biotechnology, Oil And Brazil ETFs To Watch This Week

Posted: Published on September 2nd, 2014

Markets will have a shortened week to digest new data as a result of the Labor Day weekend holiday. Here are the key ETFs to watch for the week of Monday, September 1, 2014: iShares NASDAQ Biotechnology ETF (NASDAQ: IBB ) Biotech stocks have regained their leadership status and broke out to new all-time highs last week. After a brief bout of volatility in the second quarter, these favored momentum stocks are soaring once again and topped their prior February highs. IBB is the largest ETF in this space, with $5.5 billion in total assets. This fund tracks 121 companies engaged in technology research and development for the medical field. The largest holdings in this market cap weighted vehicle include Gilead Sciences (NASDAQ: GILD ) and Celgene Corp (NASDAQ: CELG ). Related Link: Best And Worst ETFs Of The Week Amid Summer Send Off So far this year, IBB has gained nearly 22 percent and will look to add to those gains if the health care rally continues. United States Oil Fund (NYSE: USO ) Crude oil futures closed at their highest level in weeks after a multi-month sell off that included a break below $95 per barrel. USO tracks … Continue reading

Posted in Biotechnology | Comments Off on Biotechnology, Oil And Brazil ETFs To Watch This Week

Page 3,690«..1020..3,6893,6903,6913,692..3,7003,710..»